Mark J. Rosenblum

2021 - Flex Pharma

In 2021, Mark J. Rosenblum earned a total compensation of $442K as Executive Vice President, Finance and Chief Financial Officer at Flex Pharma, a 15% decrease compared to previous year.

Compensation breakdown

Bonus$152,374
Salary$278,360
Other$11,275
Total$442,010
62.98%

Rosenblum received $278.4K in salary, accounting for 63% of the total pay in 2021.

Rosenblum also received $152.4K in bonus and $11.3K in other compensation.

Rankings

In 2021, Mark J. Rosenblum's compensation ranked 10,986th out of 12,415 executives tracked by ExecPay. In other words, Rosenblum earned more than 11.5% of executives.

ClassificationRankingPercentile
All
10,986
out of 12,415
12th
Division
Manufacturing
4,848
out of 5,505
12th
Major group
Chemicals And Allied Products
2,165
out of 2,375
9th
Industry group
Drugs
1,926
out of 2,096
8th
Industry
Pharmaceutical Preparations
1,426
out of 1,546
8th
Source: SEC filing on April 28, 2022.

Rosenblum's colleagues

We found one more compensation record of an executive who worked with Mark J. Rosenblum at Flex Pharma in 2021.

2021

David Arthur

Flex Pharma

Chief Executive Officer

News

You may also like